Literature DB >> 17614368

Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.

Diana L Ford1, Mervyn J Monteiro.   

Abstract

Ubiquilin was originally identified as a presenilin-interacting protein. We previously reported that ubiquilin interacts with both the loop and carboxyl terminus of presenilin proteins and that the ubiquitin-associated (UBA) domain of ubiquilin, which binds poly ubiquitin chains, is important for mediating this interaction. In the present study, we examined whether ubiquitination of presenilin-2 (PS2) is required for interaction with ubiquilin-1 by mutating lysine residues that may be targets for ubiquitination in the presenilin loop and carboxyl terminus regions. Mutation of two lysine residues in the PS2-loop region suggested that ubiquitination is not required for interaction with ubiquilin-1 and may, in fact, even negatively regulate the interaction. Similarly, we found that ubiquitination of the PS2 carboxyl terminus (PS2-C-terminus) is not required for interaction with ubiquilin-1, although our results suggest that it could play some role. Instead, we found that the mutation of either one of the two lysine residues in the carboxyl terminus of PS2 or the proline residues in the highly conserved PALP motif in this region results in destabilization of the mutant PS2 polypeptides because of increased degradation by the proteasome. Furthermore, by GST-pull-down assays we found that the mutant polypeptides were unable to bind ubiquilin, suggesting that loss of ubiquilin interaction leads to destabilization of presenilin polypeptides. Paradoxically, however, knockdown of ubiquilin expression by RNA interference did not alter the rate of turnover of PS2 proteins in cells. Instead, we found that PS2 synthesis was reduced, and PS2 fragment production was increased, suggesting that ubiquilin expression modulates biogenesis and endoproteolysis of presenilin proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614368      PMCID: PMC2547082          DOI: 10.1021/bi700604q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting.

Authors:  Holger Richly; Michael Rape; Sigurd Braun; Sebastian Rumpf; Carsten Hoege; Stefan Jentsch
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer's disease in the UK. Mutations in brief no. 223. Online.

Authors:  M S Palmer; J A Beck; T A Campbell; C B Humphries; P K Roques; N C Fox; R Harvey; M N Rossor; J Collinge
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort.

Authors:  Rodney T Perry; Howard Wiener; Lindy E Harrell; Deborah Blacker; Rudolph E Tanzi; Lars Bertram; Susan S Bassett; Rodney C P Go
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

5.  Identification of XDRP1; a Xenopus protein related to yeast Dsk2p binds to the N-terminus of cyclin A and inhibits its degradation.

Authors:  M Funakoshi; S Geley; T Hunt; T Nishimoto; H Kobayashi
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

6.  Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.

Authors:  K Taddei; J B Kwok; J J Kril; G M Halliday; H Creasey; M Hallupp; C Fisher; W S Brooks; C Chung; C Andrews; C L Masters; P R Schofield; R N Martins
Journal:  Neuroreport       Date:  1998-10-05       Impact factor: 1.837

Review 7.  Apolipoprotein E and Alzheimer's disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

8.  Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates.

Authors:  Hiroshi Doi; Kenichi Mitsui; Masaru Kurosawa; Yoko Machida; Yoshiyuki Kuroiwa; Nobuyuki Nukina
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

9.  The presenilin C-terminus is required for ER-retention, nicastrin-binding and gamma-secretase activity.

Authors:  Christoph Kaether; Anja Capell; Dieter Edbauer; Edith Winkler; Bozidar Novak; Harald Steiner; Christian Haass
Journal:  EMBO J       Date:  2004-11-18       Impact factor: 11.598

10.  The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis.

Authors:  P M Arduengo; O K Appleberry; P Chuang; S W L'Hernault
Journal:  J Cell Sci       Date:  1998-12-18       Impact factor: 5.285

View more
  6 in total

1.  Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation.

Authors:  Jayashree Viswanathan; Annakaisa Haapasalo; Claudia Böttcher; Riitta Miettinen; Kaisa M A Kurkinen; Alice Lu; Anne Thomas; Christa J Maynard; Donna Romano; Bradley T Hyman; Oksana Berezovska; Lars Bertram; Hilkka Soininen; Nico P Dantuma; Rudolph E Tanzi; Mikko Hiltunen
Journal:  Traffic       Date:  2011-01-07       Impact factor: 6.215

2.  Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease.

Authors:  Nathaniel Safren; Lydia Chang; Kristina M Dziki; Mervyn J Monteiro
Journal:  Brain Res       Date:  2014-12-12       Impact factor: 3.252

3.  Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.

Authors:  Sang Hwa Kim; Yuling Shi; Keith A Hanson; Leah M Williams; Ryo Sakasai; Michael J Bowler; Randal S Tibbetts
Journal:  J Biol Chem       Date:  2008-12-26       Impact factor: 5.157

4.  Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage.

Authors:  Rebecca L Williamson; Karine Laulagnier; André M Miranda; Marty A Fernandez; Michael S Wolfe; Rémy Sadoul; Gilbert Di Paolo
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

Review 5.  Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation.

Authors:  Vivian Su; Alan F Lau
Journal:  Cell Mol Life Sci       Date:  2009-05-26       Impact factor: 9.261

6.  Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations.

Authors:  Lydia Chang; Mervyn J Monteiro
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.